Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001157523-11-005341
Filing Date
2011-09-09
Accepted
2011-09-09 17:29:36
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-Q/A a6856736.htm 10-Q/A 35916
  Complete submission text file 0001157523-11-005341.txt   807338

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT bstn-20110630.xml EX-101.INS 72723
3 XBRL TAXONOMY EXTENSION SCHEMA bstn-20110630.xsd EX-101.SCH 8776
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstn-20110630_cal.xml EX-101.CAL 22179
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstn-20110630_def.xml EX-101.DEF 6004
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstn-20110630_lab.xml EX-101.LAB 72291
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstn-20110630_pre.xml EX-101.PRE 51186
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-164785 | Film No.: 111084400
SIC: 2834 Pharmaceutical Preparations